NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

410 Medical Logo
Durham medical device company 410 Medical has closed on an $8 million Series A financing deal with Hatteras Venture Partners, OSF Healthcare and former investors.
TriPharm building entrance
TriPharm Services, a new Morrisville-based contract pharmaceutical development and manufacturing organization, is commissioning a new specialized manufacturing operation using the latest isolator manufacturing equipment.
Sheila Mikhail
After more than two decades of game-changing accomplishments in the life science world, AskBio CEO Sheila Mikhail has been “discovered” as the Springboard Enterprises 2019 Northstar Honoree.
Medical Murray building
For the third time since opening a Charlotte R&D and manufacturing facility in 2012, medical device company Medical Murray is celebrating the opening of an even bigger “home” in the Queen City – this one encompassing 30,000 square feet.
SEBIO logo 2019
Three early stage bioscience companies in North Carolina are among 16 companies from the Southeast selected to present their funding needs to potential investors at a major industry conference next month in Florida.
Mycovia logo
Mycovia Pharmaceuticals of Durham is partnering with a major Hungarian pharmaceutical company to commercialize and manufacture one of Mycovia’s drug candidates in Europe, Latin America, Australia, Russia and other former Soviet countries.
Duaklir Pressair inhaler
Circassia Pharmaceuticals, a British company with U.S. headquarters in Morrisville, has commercially launched Duaklir, a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), in the United States.
David Ridley, Ph.D.
Over 120 life science professionals in the race for new therapies for rare disease gathered for a full late-September day of speakers, panels, audience engagement and networking at the Rare Disease Forum at the North Carolina Biotechnology Center.
Kristie Keller, Ph.D.
How disease foundations are carving out niches and using creative models to support drug development was the focus of the first of the two-day Invest in Cures & Rare Disease Forum, hosted at the North Carolina Biotechnology Center in late September.
Piglets -- Shutterstock
Life science professionals with an interest in gastrointestinal health of either animals or humans will want to attend the North Carolina Biotechnology Center’s Animal Health & Nutrition Forum on November 4.
Waynesville Purple Carrot Location
The NCBiotech Crop Commercialization Program was created to evaluate and coordinate the introduction and market development of newer high-value crops as well as improvements for existing crops that would help North Carolina farmers.
Stevia
Farmers in the state are moving closer to a sweet new cash crop option, thanks to a research grant from the North Carolina Tobacco Trust Fund Commission to the North Carolina Biotechnology Center.
LabCorp HQ entrance
The brainchild of a Duke University medical student was transformed, over time, into one of the world’s leading life sciences companies. Now Burlington-based LabCorp is celebrating its 50th anniversary as a global life science leader.
The North Carolina Biotechnology Center awarded 18 grants and loans totaling nearly $1.4 million to bioscience companies, universities and non-profit organizations in the first quarter of its 2019-20 fiscal year.
Gibbs wastewater facility in Johnston County
A public-private partnership has cut the ribbon for a regional industrial wastewater pretreatment facility in Clayton worth $40 million.